Real-time PCR is being used increasingly as the method of choice for mRNA quanti®cation, allowing rapid analysis of gene expression from low quantities of starting template. Despite a wide range of approaches, the same principles underlie all data analysis, with standard approaches broadly classi®ed as either absolute or relative. In this study we use a variety of absolute and relative approaches of data analysis to investigate nocturnal c-fos expression in wild-type and retinally degenerate mice. In addition, we apply a simple algorithm to calculate the ampli®cation ef®ciency of every sample from its ampli®cation pro®le. We con®rm that nocturnal c-fos expression in the rodent eye originates from the photoreceptor layer, with around a 5-fold reduction in nocturnal c-fos expression in mice lacking rods and cones. Furthermore, we illustrate that differences in the results obtained from absolute and relative approaches are underpinned by differences in the calculated PCR ef®ciency. By calculating the ampli®cation ef®ciency from the samples under analysis, comparable results may be obtained without the need for standard curves. We have automated this method to provide a means of streamlining the real-time PCR process, enabling analysis of experimental samples based upon their own reaction kinetics rather than those of arti®cial standards.
INTRODUCTION
The study of gene function requires the ability to accurately quantify temporal and spatial patterns of gene expression and, given recent genomic advances, this requirement has become even more essential. Traditional approaches, such as northern blots and RNase protection assays are in many cases unsuitable, as their low sensitivity necessitates high concentrations of starting template (1, 2) . The advent of real-time PCR has enabled rapid and reproducible high throughput RT± PCR quanti®cation, with an unparalleled dynamic range and extremely high sensitivity. As such, real-time PCR is fast becoming the method of choice for the quanti®cation of gene expression, and is often recommended for the validation of microarray data (3±6). The speed with which this technique has been adopted has led to a range of potential instrumentation with a corresponding variety of¯uorescent chemistries (2, 4) . However, the same fundamental concepts underlie all approaches to gene quanti®cation by¯uorescent real-time PCR. Firstly, the principle that accumulation of¯uorescence is proportional to accumulation of ampli®cation products underpins the whole concept of quantitative PCR (7) . Secondly, the ampli®cation ef®ciency must be comparable in all samples. A difference of 5% in ampli®cation ef®ciency between two initially equal samples can result in one sample having twice as much product after 26 cycles of PCR (3) . Finally, the threshold used for analysis must be within the linear phase of all the reactions, to ensure that the threshold cycle (Ct) is truly representative of initial template differences and not just a change in reaction kinetics.
Real-time PCR data analysis methods may be broadly classi®ed as`absolute' or`relative' (8) . Absolute quanti®ca-tion involves the construction of a standard curve based upon known copy numbers, whereas relative approaches involve determining the change in expression level relative to another set of experimental samples, typically the experimental control group (8) . Whilst determining exact copy number is intuitively appealing, the generation of stable and reliable standards is both time-consuming and requires precise quanti®cation (9) . Moreover, the use of readily available nucleic acids such as plasmids introduces considerable risks of contamination. For most research applications a relative approach to quanti®cation is more practical as it compares experimental samples against controls directly.
Original methods of relative quanti®cation were based upon assuming an ideal ampli®cation ef®ciency with a doubling of product every cycle, allowing the fold change to be calculated using the formula 2 ±DDCt (8, 10) . This approach was re®ned to include the ampli®cation ef®ciency of target and internal control genes as calculated from cDNA standard curves (9) . An alternative method, requiring no standard curve, determines ampli®cation ef®ciency from the actual slope of the ampli®cation plot (11) . The major problem facing this approach is that ampli®cation ef®ciency changes throughout the PCR, with ef®ciency declining in later cycles as ampli®cation products compete for DNA polymerase binding (12 We have developed a simple algorithm for calculating the ampli®cation ef®ciency from every sample within a real-time PCR assay and have furthermore automated this calculation to allow rapid data analysis and calculation of the sources of assay variability. To test the validity of this novel method against conventional absolute and relative approaches to quantitative real-time PCR we compared the ocular expression of the immediate early gene c-fos in wild-type and retinally degenerate rd/rd cl animals (13, 14) . In darkness, retinal photoreceptors are the major source of ocular c-fos expression (15, 16) and the loss of photoreceptors in the rd/rd cl retina would therefore be expected to result in a major attenuation of nocturnal c-fos expression. Standard curves were included in the assay to allow a comparison of ®ve different approaches to real-time PCR data analysis: (i) using plasmid DNA standard curves to determine copy numbers; (ii) cDNA standard curves; (iii) the 2 ±DDCt method and a novel approach deriving ampli®cation ef®ciency from ampli®cation plots, applied as either (iv) mean ampli®cation ef®ciency or (v) as individual corrections.
MATERIALS AND METHODS

Tissue preparation, RNA extraction and reverse transcription
Wild-type and rd/rd cl mice (n = 4 each) were housed under a 12:12 h light:dark cycle for 3 weeks and killed at zeitgeber time 14 (2 h after lights off) according to Schedule 1 of the Animals (Scienti®c Research) Act. Eyes were enucleated in darkness using an infrared viewer and immediately placed in 0.5 ml of RNAlaterÔ (Ambion). Paired whole eyes were homogenised in 0.5 ml of TriReagent (Sigma Aldrich) using Fastprep tubes in a FastPrep FP 120 (Q-Biogene). Total RNA was then extracted in TriReagent according to the manufacturer's instructions. RNA was resuspended at 60°C in 20 ml of RNA Secure (Ambion). RNA concentration was determined by spectrophotometry using an Eppendorf Biophotometer. An aliquot of 1 mg of total RNA was then treated with 2 U RNasefree DNase (Sigma Aldrich) for 30 min at 37°C to remove any traces of genomic DNA. DNase-treated RNA was reverse transcribed with random decamers using a RetroScript kit (Ambion), according to the manufacturer's instructions. Once synthesised, cDNA ®delity was tested by PCR and samples were then stored at ±20°C.
Real-time PCR assay
Primers for c-fos and b-actin were designed using MacVector software (Accelrys, UK) and tested to ensure ampli®cation of single discrete bands with no primer-dimers. Primer sequences were as follows: c-fos forward, 5¢-ATCGGCAGAAGGG-GCAAAGTAG-3¢; c-fos reverse, 5¢-GCAACGCAGACTT-CTCATCTTCAAG-3¢ (174 bp product, spanning a 522 bp intron); b-actin forward, 5¢-ACCAACTGGGACGATAT-GGAGAAGA-3¢; b-actin reverse, 5¢-CGCACGATTTCCC-TCTCAGC-3¢ (403 bp product). All primers were synthesised by Sigma Genosys. PCR products for c-fos and b-actin were ligated into pGEM-T Easy vector (Promega) and transformed in DH5a competent cells (Invitrogen). Minipreps of isolated plasmid DNA were then prepared (Promega). Before use, plasmid concentration was determined by spectrophotometry using an Eppendorf BioPhotometer and serial dilutions were performed to give ®nal concentrations between 10 2 and 10 5 (c-fos) or 10 3 and 10 6 (b-actin) copies. Standard curves of cDNA were composed of three 10-fold dilutions of wild-type ocular cDNA. Real-time PCR was conducted using Sybr Green I Mastermix (Applied Biosystems) using an ABI PRISMÔ 7700 Sequence Detection System. Each reaction was run in triplicate and contained 1 ml of cDNA template along with 300 (c-fos) or 50 (b-actin) nM primers in a ®nal reaction volume of 25 ml. Cycling parameters were 95°C for 10 min to activate DNA polymerase, then 40 cycles of 95°C for 15 s and 60°C for 1 min, with a ®nal recording step of 78°C for 20 s to prevent any primer-dimer formation. Melting curves were performed using Dissociation Curves software (Applied Biosystems) to ensure only a single product was ampli®ed, and samples were also run on a 3% agarose gel to con®rm speci®city.
Data analysis
Data were analysed initially using SDS 1.7 (Applied Biosystems). For absolute copy numbers, standard curves were plotted in SDS 1.7, and also from exported data with identical results obtained by performing linear regression of log concentration against threshold cycle (Ct).
The simplest method of accurate relative quanti®cation is by calculating the theoretical value R 0 . This is based upon the simple formula used to simulate a PCR up to the point of plateau:
where X n is the concentration of template at cycle n, X 0 is the starting template concentration and E is the ampli®cation ef®ciency, having a value of 1 when exact doubling of product occurs with every additional cycle and 0 when no increase in product occurs (8) . As the basic concept underlying real-time PCR is that accumulation of¯uorescence is proportional to accumulation of ampli®cation product, the above equation may be reformulated to give the starting¯uorescence (R 0 ), which is proportional to the starting template quantity:
where Ct is the threshold cycle and R Ct is the¯uorescence at this cycle (the actual threshold used for analysis).
As the desired blunt-ended fragments ®rst appear in the third cycle of PCR (1), the ef®ciency component should more accurately be E ±(Ct ± 2) , but when conducting relative quanti®cation this discrepancy is cancelled out.
Ampli®cation plot method
The ampli®cation plot produced during real-time PCR can be used to determine the ampli®cation ef®ciency by analysing the change of¯uorescence throughout the linear phase. A novel model was applied based upon a linear regression to de®ned cycles of exponential ampli®cation, without modelling saturation kinetics. The¯uorescence maximum (R max ) of each plot was determined and the background noise of the sample (R noise ) was calculated from the standard deviation of cycles 1±10, to re¯ect the background level of¯uorescence prior to detectable ampli®cation. This provides the signal range, in which the ampli®cation rate can be determined most 
This is illustrated in Figure 1B . Using a 10-fold range around this midpoint, a minimum of three cycles within the linear phase will be utilised. This range may be extended, although an eventual decline in ef®ciency will occur due to the inclusion of cycles where the ampli®cation rate is declining or in¯uenced by background noise (see Fig. 1A ). Using a linear regression to calculate the slope of log¯uorescence around M yields a very good ®t (R 2 > 0.99) and inaccuracies introduced by low signals and reaction saturation are limited.
As shown in Figure 1A , the ampli®cation ef®ciency is highest around this midpoint. Ampli®cation ef®ciency can then be calculated from the slope:
Figure 1B illustrates an ampli®cation plot for b-actin analysed using this method, with the midpoint and selected cycles indicated.
Data handling
Data handling was simpli®ed by automating all calculations in an Excel workbook (Microsoft), entitled Data Analysis for Real-Time PCR (DART-PCR). This workbook enables the rapid calculation of threshold cycles, ampli®cation ef®ciency and resulting R 0 values (along with the associated error) from raw data exported from SDS 1.7. Differences in ampli®cation ef®ciency are assessed using one-way analysis of variance (ANOVA), based upon the null hypotheses: (i) that ampli®-cation ef®ciency is comparable within sample groups (outlier detection); (ii) that ampli®cation ef®ciency is comparable between sample groups (ampli®cation equivalence). Differences between normalised wild-type and rd/rd cl c-fos expression were assessed using a two-tailed Student's t-test assuming unequal variance.
RESULTS
Absolute quanti®cation
Absolute quanti®cation was conducted using copy numbers derived from plasmid standards. The term`absolute' is perhaps misleading as the copy numbers derived are relative to the standard used.
b-Actin levels in wild-type and rd/rd cl eyes were determined to be highly comparable, with around 409 186 copies in wild-type and 421 917 copies in rd/rd cl. The comparable levels of b-actin expression given equivalent RNA loading demonstrate that this gene is a suitable internal control for normalising RNA loading in this experimental context (17, 18) .
As expected, in comparison to wild-type mice, rd/rd cl animals demonstrate a much lower expression of c-fos in ocular tissues. The expression of ocular c-fos was determined as 19 646 copies in wild-type, compared with 4256 copies in rd/rd cl. When c-fos expression was normalised to b-actin, this resulted in a signi®cant decrease of 4.78-fold (P < 0.001), as illustrated in Figure 2A .
The intra-assay variability was calculated from reaction triplicates as 4.2 and 17.5% for c-fos (wild-type and rd/rd cl) and 4.3 and 2.3% for b-actin (wild-type and rd/rd cl). This compares favourably with previous calculations of real-time variability, of 14.2% for Sybr Green and 24.0% for TaqManÔ (19) , and furthermore suggests that intra-assay variability may be both primer and template dependent. Higher intra-assay variability for c-fos in rd/rd cl may be an effect of lower starting template concentration. Both plasmid and cDNA standard curves demonstrated higher variability at lower concentrations (data not shown).
Relative quanti®cation
To compare the accuracy of ef®ciency-corrected relative quanti®cation, ampli®cation ef®ciency was derived from cDNA standard curves (see Table 2 ). Using equation 2, R 0 was calculated for c-fos expression normalised to b-actin. The result showed a signi®cant decrease (P < 0.001), with a 4.60-fold lower expression of c-fos in rd/rd cl compared to wild-type eyes.
The same data was also analysed using the 2 ±DDCt method, again resulting in a signi®cant decrease in ocular c-fos in rd/rd cl animals (P < 0.001). In this case, the fold decrease was determined as 5.80. The overestimation of the difference in 
expression is produced by the assumption of an ideal ampli®cation ef®ciency of 1.
Ampli®cation plot method
Using the slope of real-time PCR ampli®cation plots as described, the mean ampli®cation ef®ciency was determined as 0.846 for c-fos and 0.874 for b-actin. When the mean ampli®cation ef®ciency was used with equation 2 to calculate relative expression, the reduction in c-fos expression in the rd/rd cl eye was determined as 4.79 (P < 0.001). The results of data analysis are shown in Figure 2B and summarised in Table 1 .
To test the effects of applying individual reaction corrections, relative quanti®cation using the ampli®cation ef®ciency of every individual sample was also conducted. Following these corrections a signi®cant decrease in expression was still apparent, although this difference was determined as 3.55-fold (P < 0.05).
There was no signi®cant difference between the reaction ef®ciencies of wild-type (c-fos 0.839, b-actin 0.872) and rd/rd cl (c-fos 0.852, b-actin 0.876) samples as tested by ANOVA and no individual sample within any of the groups demonstrated a signi®cantly different ef®ciency. Applying individual corrections appears unjusti®ed based upon these ®ndings and rather than improving accuracy, introduces systematic errors which exaggerate the difference in expression and increase the assay noise.
Validation of the ampli®cation plot method on known concentrations
To test the accuracy of the ampli®cation plot method on samples of known concentration, data from standard curves were also analysed. Table 3 shows data from b-actin standard curves analysed using R 0 values and shows a very close approximation to the actual dilutions used in the standard curves (r 2 > 0.998). These calculated dilutions are not exact, even when using the ef®ciency derived from the standard curve, indicating that errors must be apparent in the standard curve construction.
Given extremely precise pipetting a 1% relative error may be expected (Gilson), and following a 10-fold dilution this translates to an error of up to 1% in ef®ciency. Pipetting errors directly affect the calculated ampli®cation ef®ciency, and cumulative error, particularly given imprecise pipetting or poorly calibrated pipettes, can therefore result in considerable effects on the accuracy of the ampli®cation ef®ciency calculated from standard curves. A value of 0 corresponds to no ampli®cation, whereas 1 indicates a perfect doubling of product with every cycle. Ef®ciency was calculated from plasmid and cDNA standard curves using a modi®ed version of equation 4, where E = 10 (±1/slope) ± 1 and from ampli®cation plots using equations 3 and 4 (see text for details). The standard deviation associated with this ef®ciency is noted where calculated. Discrepancies between the ef®ciency values for c-fos and b-actin may be due to errors in ef®ciency calculation or standard curve construction or may represent differences in ef®ciency between the templates used. Based upon this data, an approximate¯uorescence per copy can be calculated as~4.06 Q 10 ±13 for b-actin (based on 1 Q 10 6 copies to minimise dilution errors), which corrected for amplicon size results in~1.01 Q 10 ±13 per 100 bp of product. Fluorescence per copy may be expected to be proportional to product size with a double-stranded DNA-binding dye such as Sybr Green I. In this study, we calculated the¯uorescence per copy for c-fos as 2.03 Q 10 ±13 , which corresponds to 1.17 Q 10 ±13 per 100 bp.
DISCUSSION
The nocturnal expression of the immediate early gene c-fos within the murine eye was found to be signi®cantly lower in rd/rd cl animals in comparison to wild-type. Given the loss of rod and cone photoreceptors in this model, this supports previous reports that the source of nocturnal c-fos expression in the rodent eye is the photoreceptor layer (15, 16) .
These data demonstrate that absolute (copy number) and relative (fold change) approaches to real-time PCR produce very similar results, as summarised in Table 1 . All of the ®ve methods applied to data analysis demonstrate that c-fos expression is signi®cantly reduced in the rd/rd cl eye in comparison to the wild-type. The magnitude of this change and associated variance are extremely comparable between plasmid DNA standard curves, cDNA standard curves and the mean ef®ciency ampli®cation plot methods. The 2 ±DDCt method provides a good approximation, although the assumption of an ampli®cation ef®ciency of 1 exaggerates the difference. The least comparable method of data analysis is applying individual sample corrections, as this introduces considerable systematic errors in data analysis, as discussed below. As can be seen from Table 2 , the only practical difference between these approaches is the way in which ampli®cation ef®ciency is calculated and how this correction is subsequently applied.
Standard curve methods have become widely used for the purpose of calibrating real-time PCR reactions against known concentrations of nucleic acids. Whilst standard preparations such as amplicon, plasmid, oligonucleotide or synthesised RNA provide a readily available source for standard curve construction, use of these puri®ed standards is dependent upon the assumption that the ampli®cation ef®ciency of standard and cDNA samples is identical. Whilst this may be true, it is rarely tested and samples of cDNA may in fact possess secondary structure or contain PCR inhibitors remaining from the RNA extraction, DNase treatment or reverse transcription steps, all of which may subtly affect PCR ef®ciency (1, 20) . By using cDNA to construct standard curves, differences between the ampli®cation ef®ciency of standard and template may be circumvented (9) . However, the range of a cDNA standard curve is limited by the expression level in the sample used (particularly for rare transcripts) and only represents that sample. The dilution steps involved in constructing standard curves raise additional problems. Lower starting template concentrations result in greater assay variability, making the higher dilutions of a standard curve less reliable. Furthermore, the concentration of nucleic acids present in the reaction may adversely affect ampli®cation ef®ciency (12) , necessitating the use of a carrier nucleic acid.
Copy numbers derived from standards are also prone to error, and in many cases may be meaningless. Cumulative errors introduced by spectrophotometry, calculations of molecular weight and pipetting errors result in copy numbers being an approximation rather than an absolute unit. Furthermore, the copy number in experimental samples may not be comparable due to differences in RNA concentration, RNA quality and reverse transcription rates, all of which may vary considerably and are dif®cult to control for (3). For example, a sample containing partially degraded RNA will return a lower copy number, whereas a sample undergoing ef®cient reverse transcription will contain a higher copy number.
In most biological applications, gene expression data are normalised to one or more internal controls to account for these differences (17, 18) . This results in an expression ratio of target gene to internal control. This process of normalisation is not what is meant by`relative' quanti®cation; it is when the normalised experimental samples are then calibrated to the normalised control samples that a relative expression value is derived (10) . The relative expression is simply the ratio between normalised samples, and the result is the same whether the measurements used are copy numbers or theoretical values such as R 0 . This is illustrated by calculating the R 0 using the ampli®cation ef®ciency derived from the plasmid DNA standard curves in this study. When calculated as relative expression, the fold change and data variance observed are mathematically identical to those obtained with copy numbers.
Fluorescence must be proportional to DNA content for realtime PCR techniques to be valid (3). This is con®rmed by the calculation of R 0 per molecule (when normalised to amplicon size), which suggests a value for both c-fos and b-actin of around 1 Q 10 ±13 per 100 bp of amplicon. This also suggests that increasing amplicon size may be a simple means of increasing assay sensitivity when using double-stranded DNA binding dyes such as Sybr green 1.
As the determination of ampli®cation ef®ciency critically underpins accurate real-time PCR, a means of monitoring ampli®cation ef®ciency of all samples is desirable. Whilst the exact magnitude of a difference in expression may not be essential, ensuring that all samples exhibit comparable ampli®cation ef®ciency certainly is (3) . The use of raw data to determine ampli®cation ef®ciency provides a powerful means of determining PCR ef®ciency in every single reaction.
The novel method we present here allows an automated calculation of ampli®cation ef®ciency for every sample in a Figure 2 , illustrating that the ®nal results are indistinguishable. Individual sample ef®ciency corrections can be applied using this method and one may assume that would provide improved precision. However, applying individual corrections leads to the introduction of additional error (see Table 1 ). This apparently counter-intuitive result re¯ects the impact of ampli®cation ef®ciency on ®nal results. The number of cycles over which the ampli®cation ef®ciency is near maximum (but free of background noise) is surprisingly limited and there may only be a small number of available data points above the detection threshold before the ampli®cation rate starts to decline (see Fig. 1A ). As such, determination of ampli®cation ef®ciency is limited by errors in measurement.
Several previous methods have suggested the use of individual corrections (11, 21) , and whilst this would seem the obvious approach, it is in fact impractical due to the likelihood of introducing considerable systematic errors, as demonstrated herein. These errors are due to the relationship between ampli®cation ef®ciency (E) and R 0 , as described in equation 2. Any correction based upon E is capable of having dramatic effects on the resulting R 0 value due to the exponential magni®cation of this value. Therefore, if different E values are used for each sample, any error in the measured E will be exponentially magni®ed, and even very small errors in E will result in a considerable effect on R 0 . This is simply illustrated by comparing three hypothetical samples, A±C, each with a Ct of 26.15 at a threshold (R Ct ) of 0.06, but with differing ampli®cation ef®ciencies. If E = 0.85 for Sample A, 0.84 for Sample B and 0.80 for Sample C, the R 0 values would therefore be 6.19 Q 10 ±9 , 7.13 Q 10 ±9 and 1.27 Q 10 ±8 , respectively. Relative to Sample A, expression in Sample B is therefore 15% higher, whereas Sample C is 105% higher. As can be seen from this example, even a difference in ampli®cation ef®ciency of 0.01 can have a signi®cant in¯uence on the R 0 value, and a difference of just 0.05 yields a wholly different interpretation of the data.
All measurements of ampli®cation rate are estimates, and the most reliable estimates are based upon repeated measurements. As such, when using ampli®cation ef®ciencies derived from individual sample kinetics the mean ampli®cation ef®ciency provides a more accurate measure of ef®ciency than individual corrections, which if even slightly inaccurate may distort results rather than providing increased precision. We have found this to be the case in all data sets examined, with signi®cantly increased data variance following application of individual corrections.
As such, one must assume that ampli®cation ef®ciency is comparable unless there is suf®cient evidence to suggest otherwise. By using the mean ef®ciency, and incorporating tests for outlier detection within groups and for differences between groups, we can be certain that samples exhibit comparable kinetics and corrections are only applied when suf®cient statistical evidence exists to justify them.
Finally, measures of intra-assay variability are easily calculated (for ef®ciency and R 0 ) using replicate reactions, and this provides a measure of the inherent experimental error, to which the operator may contribute signi®cantly (4) . The calculation of intra-assay variability should be based upon copy numbers or R 0 and not upon Ct values, as the latter are logarithmic units and as such result in a misleading representation of reproducibility (19) .
CONCLUSIONS
This study supports the hypothesis that nocturnal expression of ocular c-fos originates from the photoreceptor layer. In addition, we illustrate that absolute and relative approaches to real-time PCR data analysis provide very comparable end results and that the key difference between these approaches are produced by the ampli®cation ef®ciency applied. Whilst standard curves are widely used for calculating ampli®cation ef®ciency, they are based upon the assumption that the ampli®cation ef®ciencies of the diluted standard and unknown samples are identical. Furthermore, the copy numbers often produced may actually give a misleading interpretation.
Given that every ampli®cation plot contains information regarding the ampli®cation kinetics of the sample, it is instead possible to use this data to determine the ampli®cation ef®ciency. By calculating the ampli®cation ef®ciency for every sample, it is then a simple matter to test for outliers and to ensure that sample and control populations exhibit similar kinetics. Due to the potential for introducing considerable systematic errors, ampli®cation ef®ciency must be assumed to be comparable unless evidence exists to suggest otherwise. We have automated all the necessary calculations and statistical tests to allow a simple and effective means of analysing real-time PCR data, enabling the assay to be conducted rapidly based upon the kinetics of experimental samples, rather than additional arti®cial standards.
